<DOC>
	<DOCNO>NCT00469443</DOCNO>
	<brief_summary>This phase III study compare two combination irinotecan , Folfiri versus Xeliri , addition Avastin 1st line treatment colorectal cancer .</brief_summary>
	<brief_title>Randomized Phase III Study Folfiri+Avastin Versus Xeliri+Avastin 1st Line Treatment CRC</brief_title>
	<detailed_description>There data comparison Folfiri Xeliri regimens . The report data demonstrate addition Avastin combination irinotecan/bolus 5-FU/LV significant improvement overall survival . Further analysis result show patient receive irinotecan combination Avastin , 1st line treatment oxaliplatin Avastin , second line treatment , median overall survival 25 , 1 month , long survival report .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Histologically confirm locally advanced metastatic colorectal cancer Measurable evaluable disease ECOG performance status ≤ 2 Age 18 72 year Adequate liver ( Bilirubin ≤ 1.5 UNL , SGOT/SGPT ≤ 4 UNL , ALP ≤ 2.5 UNL ) , renal ( Creatinine ≤ 1.5 UNL ) bone marrow ( ANC ≥ 1,500/mm3 , PLT ≥ 100,000/mm3 ) function Patients history hemoptysis increase risk thromboembolic event observe carefully due administration Avastin Patients must able understand nature study Written inform consent Previous 1st line chemotherapy Adjuvant chemotherapy Irinotecan regimen relapse &lt; 6 month completion Active infection History serious cardiac disease ( unstable angina , congestive heart failure , myocardial infarction within previous 6 month , ventricular arrhythmia ) Previous radiotherapy within last 4 week &gt; 25 % bone marrow Patients unstable CNS metastases Patients chronic diarrhea ( least 3 month ) partial bowel obstruction Second primary malignancy , except nonmelanoma skin cancer situ cervical cancer Psychiatric illness social situation would preclude study compliance Pregnant lactate woman Patients &gt; 65 year history arterial thromboembolic , myocardial infarction , unstable angina pulmonary embolism</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Metastatic colorectal cancer</keyword>
	<keyword>Irinotecan</keyword>
	<keyword>Capecitabine</keyword>
	<keyword>Bevacizumab</keyword>
</DOC>